Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NutraMeltz is a Canadian nutraceutical company specializing in the development and manufacture of innovative oral disintegrating tablets (ODT). The company utilizes a proprietary fast-melting technology that allows supplements to dissolve quickly in the mouth without the need for water, enhancing bioavailability and convenience for consumers. Their product portfolio includes a wide range of vitamins, minerals, and herbal supplements such as Melatonin, Methylcobalamin (B12), and Iron. NutraMeltz focuses on providing effective delivery solutions for individuals who have difficulty swallowing traditional pills or capsules, such as pediatric and geriatric populations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NutraMeltz.